AR024686A1 - Un metodo para sintetizar un peptido - Google Patents

Un metodo para sintetizar un peptido

Info

Publication number
AR024686A1
AR024686A1 ARP000103508A ARP000103508A AR024686A1 AR 024686 A1 AR024686 A1 AR 024686A1 AR P000103508 A ARP000103508 A AR P000103508A AR P000103508 A ARP000103508 A AR P000103508A AR 024686 A1 AR024686 A1 AR 024686A1
Authority
AR
Argentina
Prior art keywords
peptide
peptides
seq
group
protected side
Prior art date
Application number
ARP000103508A
Other languages
English (en)
Spanish (es)
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trimeris Inc filed Critical Trimeris Inc
Publication of AR024686A1 publication Critical patent/AR024686A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ARP000103508A 1999-07-07 2000-07-07 Un metodo para sintetizar un peptido AR024686A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/349,205 US6469136B1 (en) 1999-07-07 1999-07-07 Methods and composition for peptide synthesis

Publications (1)

Publication Number Publication Date
AR024686A1 true AR024686A1 (es) 2002-10-23

Family

ID=23371340

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103508A AR024686A1 (es) 1999-07-07 2000-07-07 Un metodo para sintetizar un peptido

Country Status (17)

Country Link
US (2) US6469136B1 (enExample)
EP (1) EP1372686B1 (enExample)
JP (1) JP2003530311A (enExample)
KR (1) KR100631874B1 (enExample)
CN (1) CN1267449C (enExample)
AR (1) AR024686A1 (enExample)
AT (1) ATE288278T1 (enExample)
AU (1) AU4133701A (enExample)
BR (1) BR0012249A (enExample)
CA (1) CA2378086A1 (enExample)
DE (1) DE60017955T2 (enExample)
DK (1) DK1372686T3 (enExample)
ES (1) ES2236043T3 (enExample)
MX (1) MXPA02000021A (enExample)
PT (1) PT1372686E (enExample)
TW (1) TWI237640B (enExample)
WO (1) WO2001034635A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
WO2004013165A1 (en) * 2002-07-24 2004-02-12 F. Hoffmann-La Roche Ag Pegylated t1249 polypeptide
US20040158037A1 (en) * 2003-02-12 2004-08-12 Bohling James Charles Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
ES2558102T3 (es) * 2003-05-06 2016-02-02 Biogen Hemophilia Inc. Proteínas quiméricas del factor de coagulación para el tratamiento de un trastorno hemostático
WO2005063792A2 (en) * 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support
ATE410437T1 (de) * 2003-12-31 2008-10-15 Hoffmann La Roche Verfahren und systeme zur rückgewinnung von peptiden
EP1701971A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Peptide synthesis using decanting filter
DE602004009710T2 (de) * 2003-12-31 2008-08-07 F. Hoffmann-La Roche Ag Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
WO2005063799A2 (en) * 2003-12-31 2005-07-14 F.Hoffmann-La Roche Ag Peptide synthesis and deprotection with co-solvent
JP4805911B2 (ja) * 2004-03-15 2011-11-02 ネクター セラピューティクス Ｈｉｖ侵入阻害剤のポリマー系組成物及び複合体
DE602005017188D1 (de) * 2004-12-30 2009-11-26 Hoffmann La Roche Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte
WO2006069779A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Preparing of peptides with excellent solubility
CA2593866C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis of peptide t-1249 using peptide intermediate fragments
WO2006069697A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Colorimetrically assessing peptide characteristics
WO2006105199A2 (en) * 2005-03-30 2006-10-05 Trimeris, Inc. Compositions and methods for synthesis of peptide and related conjugate
TW200745163A (en) * 2006-02-17 2007-12-16 Syntonix Pharmaceuticals Inc Peptides that block the binding of IgG to FcRn
CA2651070A1 (en) 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
CN101195653B (zh) * 2006-12-08 2010-05-12 吉尔生化（上海）有限公司 亮丙瑞林的固液合成法
EA201070231A1 (ru) * 2007-08-09 2010-10-29 Синтоникс Фармасьютикалз, Инк. Иммуномодулирующие пептиды
CA2700354A1 (en) * 2007-09-25 2009-04-02 Trimeris, Inc. Novel methods of synthesis for therapeutic antiviral peptides
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
WO2009074483A2 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20100048488A1 (en) * 2008-08-01 2010-02-25 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
EA201291482A1 (ru) 2010-07-09 2013-10-30 Байоджен Айдек Хемофилия Инк. Химерные факторы коагуляции
CN102268065A (zh) * 2011-06-23 2011-12-07 成都圣诺科技发展有限公司 氨基保护丝氨酸寡肽及其制备方法和用途
CN102603869B (zh) * 2012-03-27 2013-03-27 西安华澳丽康生物工程有限公司 六胜肽的合成方法
SG10201707600XA (en) 2013-03-15 2017-11-29 Biogen Ma Inc Factor ix polypeptide formulations
EP2976331B1 (en) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthesis of hydantoin containing peptide products
CA2907521C (en) 2013-03-21 2021-04-13 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
CN108572171A (zh) * 2017-03-10 2018-09-25 江苏金斯瑞生物科技有限公司 一种检测哌啶残留的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2139017T3 (es) 1992-07-20 2000-02-01 Univ Duke Compuestos que inhiben la replicacion del vih.
JP3401005B2 (ja) 1992-12-11 2003-04-28 ユニバーシティ オブ フロリダ 有害生物の防除のための材料および方法
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
CA2164505A1 (en) 1993-06-07 1994-12-22 Phillip W. Berman Hiv envelope polypeptides
ES2245505T3 (es) * 1998-03-23 2006-01-01 Trimeris Inc. Metodos y composiciones para la sintesis de peptidos (t-20).
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6217666B1 (en) 1998-08-31 2001-04-17 Danieli Technology, Inc. Countercurrent reduction of oxides on moving metal

Also Published As

Publication number Publication date
MXPA02000021A (es) 2002-07-02
WO2001034635A9 (en) 2002-08-01
ES2236043T3 (es) 2005-07-16
CA2378086A1 (en) 2001-05-17
DE60017955D1 (de) 2005-03-10
DE60017955T2 (de) 2006-01-12
CN1450906A (zh) 2003-10-22
CN1267449C (zh) 2006-08-02
TWI237640B (en) 2005-08-11
WO2001034635A2 (en) 2001-05-17
DK1372686T3 (da) 2005-05-30
JP2003530311A (ja) 2003-10-14
KR20020038676A (ko) 2002-05-23
US6767993B2 (en) 2004-07-27
EP1372686A2 (en) 2004-01-02
AU4133701A (en) 2001-06-06
US6469136B1 (en) 2002-10-22
PT1372686E (pt) 2005-05-31
EP1372686B1 (en) 2005-02-02
US20030125516A1 (en) 2003-07-03
WO2001034635A3 (en) 2003-10-16
BR0012249A (pt) 2003-11-11
KR100631874B1 (ko) 2006-10-09
EP1372686A4 (en) 2004-01-02
ATE288278T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
AR024686A1 (es) Un metodo para sintetizar un peptido
BRPI9909018B8 (pt) processo para a síntese de um peptídeo
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
BR9909018A (pt) Processo para a sìntese de um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo
BR0314071A (pt) Derivados de pró-droga de 1,3-diamino-2-hidroxipropano
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
DK2027152T3 (da) Peptidfragmenter til induktion af syntese af ekstracellulære matrixproteiner
CY1113850T1 (el) Νεα παραγωγα ινσουλινης
BR9910296A (pt) Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado
BR0114630A (pt) Secretagogos de hormÈnio do crescimento
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
UA103882C2 (uk) Композиція пухлино-асоційованих пептидів та відповідна протиракова вакцина
BR0309712A (pt) Processo para a preparação de carbonitrilas 7-substituìda-3-quinolina e 3-quinol-4-ona
BR9807349A (pt) Composto, processos para preparar um composto e para preparar 6-o-alquil eritromicina a.
MXPA06000854A (es) Polipeptidos para inducir una respuesta inmune protectora en contra de staphylococcus aureus.
AR074944A1 (es) Proceso para la produccion de bivalirudina
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR9407693A (pt) Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto
BRPI0416916A (pt) promotores para expressão em vìrus de vacìnia modificada ankara
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
FI956055A0 (fi) Tekijä VII:sta johdettuja peptidejä
BR0315971A (pt) Método para inibir o desenvolvimento de câncer por inibidores de sintase de ácido graxo
BRPI0309195B8 (pt) derivados organossilicone de amino hidroxibenzofenonas, polímero de diorganossiloxano linear, processo para preparação dos referidos derivados, composição cosmética e uso dos referidos derivados como filtros de uv-a em preparações comésticas
BRPI0413437A (pt) preparação de peptìdeos de somatostatina
BR0209842A (pt) Processo para a preparação de imipenem

Legal Events

Date Code Title Description
FG Grant, registration